Medicines Safety in Dementia Care: Practical Systems That Prevent Harm and Stand Up to Scrutiny
Medicines risk in dementia care rarely stems from a single error. It reflects weak systems, rushed routines and poor escalation when frailty increases. Effective providers embed medicines governance within dementia medicines, falls and frailty structures and align processes with robust dementia service models. Commissioners and inspectors expect evidence of safe administration, proportionate PRN use, deprescribing review and clear links between medicines changes and falls or delirium risk.
Polypharmacy and cumulative frailty risk
Older people with dementia often take multiple medications. Sedatives, antihypertensives and anticholinergics can increase falls, confusion and dehydration risk. Medicines safety must therefore integrate with frailty management.
Operational example 1: PRN use linked to falls incidents
Context: A resident receives frequent PRN anxiolytics following evening agitation.
Support approach: Medicines review explores non-pharmacological alternatives.
Day-to-day delivery detail: Staff trial earlier evening routines, sensory interventions and hydration prompts. PRN administration requires behaviour rationale documentation and manager review within 24 hours.
How effectiveness is evidenced: PRN frequency reduces by 60%, evening falls decrease and audit confirms improved documentation quality.
Operational example 2: Deprescribing after postural hypotension
Context: Recurrent dizziness noted on standing.
Support approach: GP reviews antihypertensive regime.
Day-to-day delivery detail: Orthostatic blood pressure monitoring is recorded for one week. Staff delay mobilisation briefly after morning doses. Care plans updated to reflect revised guidance.
How effectiveness is evidenced: Improved standing tolerance and reduced near-miss falls documented.
Operational example 3: Missed dose governance audit
Context: Audit identifies repeated late evening omissions.
Support approach: Workflow review identifies staffing overlap gap.
Day-to-day delivery detail: Administration times adjusted, second checker introduced for high-risk medicines and competency refresher delivered.
How effectiveness is evidenced: Omission rate drops below 1%, with monthly governance reports tracking compliance.
Commissioner expectation: medicines optimisation and harm reduction
Commissioner expectation: Commissioners expect evidence of regular medicines review, pharmacist involvement and demonstrable reduction in medicines-related incidents.
Regulator / Inspector expectation (CQC): safe systems and competent staff
Regulator / Inspector expectation (CQC): Inspectors assess staff competence, accurate records and whether medicines decisions reflect best interest, least restrictive and proportionate principles.
Embedding inspection-ready medicines governance
Quarterly medicines audits, PRN trend analysis and integrated falls review ensure systems are robust. When medicines safety links clearly to frailty and falls prevention, services reduce avoidable harm and evidence defensible practice.